We are live on ! Find out more
MBOT icon

Microbot Medical
MBOT

25 hedge funds and large institutions have $6.77M invested in Microbot Medical in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 3

28% more capital invested

Capital invested by funds: $5.28M → $6.77M (+$1.49M)

0.4% more ownership

Funds ownership: 10.78% → 11.18% (+0.4%)

4% less funds holding

Funds holding: 26 → 25 (-1)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

Holders
25
Holders Change
-1
Holders Change %
-3.85%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$170K
2
Citadel Advisors
Citadel Advisors
Florida
+$142K
3
Millennium Management
Millennium Management
New York
+$96.6K
4
IMA
Investment Management Associates
Colorado
+$86K
5
Barclays
Barclays
United Kingdom
+$24.3K

Top Sellers

Rank Fund Capital Flow
1
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$112K
2
Renaissance Technologies
Renaissance Technologies
New York
-$112K
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$11.5K
4
Morgan Stanley
Morgan Stanley
New York
-$8.59K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$34
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.3M +$170K +19,800 +8%
BlackRock
2
BlackRock
New York
$1.65M +$21.9K +2,551 +1%
AA
3
AlphaCentric Advisors
Puerto Rico
$851K – – –
XI
4
XXEC Inc
Oklahoma
$788K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$429K – – –
Bank of New York Mellon
6
Bank of New York Mellon
New York
$156K -$11.5K -1,340 -7%
Citadel Advisors
7
Citadel Advisors
Florida
$140K +$142K +16,493 New
Northern Trust
8
Northern Trust
Illinois
$101K +$972 +113 +1%
SPIA
9
Steward Partners Investment Advisory
New York
$98.7K – – –
Millennium Management
10
Millennium Management
New York
$96K +$96.6K +11,231 New
IMA
11
Investment Management Associates
Colorado
$85K +$86K +10,000 New
Barclays
12
Barclays
United Kingdom
$24K +$24.3K +2,825 +282,500%
Morgan Stanley
13
Morgan Stanley
New York
$17K -$8.59K -999 -33%
Wells Fargo
14
Wells Fargo
California
$11K +$17 +2 +0.2%
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$5K -$34 -4 -0.6%
UBS Group
16
UBS Group
Switzerland
$3K +$2.67K +310 +15,500%
Osaic Holdings
17
Osaic Holdings
Arizona
$2K – – –
PFGIA
18
Patriot Financial Group Insurance Agency
Massachusetts
$1K – – –
RE
19
RBC Europe
United Kingdom
$9 – – –
SIS
20
Sound Income Strategies
Florida
$9 – – –
Renaissance Technologies
21
Renaissance Technologies
New York
– -$112K -16,200 Closed
Qube Research & Technologies (QRT)
22
Qube Research & Technologies (QRT)
United Kingdom
– -$112K -16,191 Closed
HI
23
Harbour Investments
Wisconsin
– +$17 +2 New
Bank of America
24
Bank of America
North Carolina
– +$232 +27 +675%

MBOT Hedge Fund Activity: Q1 2021 in Review

25 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q1 2021, worth a combined $6.77M — up 28% from $5.28M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of MBOT and 4 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 7 added.

The largest buyer was Vanguard Group, adding an estimated $170K. The largest seller was Qube Research & Technologies (QRT), exiting entirely with an estimated $112K sold.

  • 25 institutional investors held Microbot Medical (MBOT) as of Q1 2021, down from 26 in Q4 2020.
  • Funds reported $6.77M of Microbot Medical stock for Q1 2021, up 28% quarter-over-quarter.
  • 4 funds opened new Microbot Medical positions in Q1 2021 and 5 closed out, a net change of -1 holder.
  • The largest Microbot Medical buyer in Q1 2021 was Vanguard Group, an estimated $170K added.
  • The largest Microbot Medical seller in Q1 2021 was Qube Research & Technologies (QRT), an estimated $112K sold.

Based on aggregated 13F filings for Q1 2021.